Cargando…

Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study

PURPOSE: There are conflicting results on the potential role of HER2-status on the efficacy of aromatase inhibitors (AIs) and tamoxifen (TAM) in patients with hormone receptor (HR)-positive breast cancer (BC). The purpose of this population-based cohort study was to investigate the potential benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiza, Aglaia, Mauri, Davide, Fredriksson, Irma, Anna-Karin Wennstig, Valachis, Antonios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019428/ https://www.ncbi.nlm.nih.gov/pubmed/33258078 http://dx.doi.org/10.1007/s10549-020-06022-5

Ejemplares similares

De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study
por: Schiza, Aglaia, et al.
Publicado: (2023)

Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study
por: Plym, Anna, et al.
Publicado: (2020)

Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
por: Valachis, Antonis, et al.
Publicado: (2016)

Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
por: Sund, Maria, et al.
Publicado: (2021)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort
por: Wennstig, Anna-Karin, et al.
Publicado: (2020)

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
por: Joona, Therse Björkin, et al.
Publicado: (2020)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Wennstig, Anna-Karin, et al.
Publicado: (2021)

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020)

Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
por: Suzuki, R, et al.
Publicado: (2008)

Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort
por: Nyante, S J, et al.
Publicado: (2014)

Postmenopausal overweight and breast cancer risk; results from the KARMA cohort
por: Klintman, Marie, et al.
Publicado: (2022)

Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population
por: Chen, Ruixian, et al.
Publicado: (2022)

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016)

Loss in working years after a breast cancer diagnosis
por: Plym, Anna, et al.
Publicado: (2018)

Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer
por: James, Rani, et al.
Publicado: (2011)

Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
por: Sund, Maria, et al.
Publicado: (2023)

Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact
por: Johansson, Anna L. V., et al.
Publicado: (2018)

Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study
por: Monroe, K R, et al.
Publicado: (2007)

Risk of coronary stenosis after adjuvant radiotherapy for breast cancer
por: Wennstig, A.-K., et al.
Publicado: (2022)

Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study
por: Kawai, M, et al.
Publicado: (2010)

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
por: Güth, U, et al.
Publicado: (2008)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
por: Gallagher, Christopher M., et al.
Publicado: (2016)

Cohort study of the association of hypnotic use with mortality in postmenopausal women
por: Hartz, Arthur, et al.
Publicado: (2012)

Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
por: González-Zuloeta Ladd, A. M., et al.
Publicado: (2007)

HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series
por: Rothschild, Harriet T., et al.
Publicado: (2023)

Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study
por: Sund, Malin, et al.
Publicado: (2022)

Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer
por: Katuwal, Sushmita, et al.
Publicado: (2022)

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
por: Fadelu, Temidayo A., et al.
Publicado: (2022)

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
por: Yardley, D A, et al.
Publicado: (2014)

Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women
por: Clavel-Chapelon, F
Publicado: (2002)

Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer
por: Onland-Moret, N C, et al.
Publicado: (2003)

Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers
por: Yaghjyan, Lusine, et al.
Publicado: (2015)

Long-term outcome in young women with breast cancer: a population-based study
por: Fredholm, Hanna, et al.
Publicado: (2016)

Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC
por: Colomer, R., et al.
Publicado: (2017)

Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience
por: Levy, Julia, et al.
Publicado: (2022)

Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study
por: Krotneva, Stanimira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t44efennklu87qksi00sck5nbf